ArticleCancers2020

Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells.

Margherita Passariello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.